Ocular Therapeutix, Inc. (OCUL)
8.73
+0.26
(+3.07%)
USD |
NASDAQ |
Jun 10, 16:00
8.73
0.00 (0.00%)
After-Hours: 17:21
Ocular Therapeutix EPS Diluted (TTM) : -1.456 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.456 |
| December 31, 2025 | -1.438 |
| September 30, 2025 | -1.436 |
| June 30, 2025 | -1.278 |
| March 31, 2025 | -1.149 |
| December 31, 2024 | -1.262 |
| September 30, 2024 | -1.320 |
| June 30, 2024 | -1.355 |
| March 31, 2024 | -1.356 |
| December 31, 2023 | -1.256 |
| September 30, 2023 | -1.112 |
| June 30, 2023 | -1.173 |
| March 31, 2023 | -1.155 |
| December 31, 2022 | -0.9859 |
| September 30, 2022 | -1.010 |
| June 30, 2022 | -0.9305 |
| March 31, 2022 | -0.9365 |
| December 31, 2021 | -0.9524 |
| September 30, 2021 | -1.939 |
| June 30, 2021 | -1.894 |
| March 31, 2021 | -2.278 |
| December 31, 2020 | -2.454 |
| September 30, 2020 | -1.778 |
| June 30, 2020 | -2.034 |
| March 31, 2020 | -1.967 |
| Date | Value |
|---|---|
| December 31, 2019 | -2.005 |
| September 30, 2019 | -1.892 |
| June 30, 2019 | -1.831 |
| March 31, 2019 | -1.631 |
| December 31, 2018 | -1.578 |
| September 30, 2018 | -1.595 |
| June 30, 2018 | -1.75 |
| March 31, 2018 | -2.02 |
| December 31, 2017 | -2.20 |
| September 30, 2017 | -2.28 |
| June 30, 2017 | -2.13 |
| March 31, 2017 | -1.95 |
| December 31, 2016 | -1.81 |
| September 30, 2016 | -1.72 |
| June 30, 2016 | -1.80 |
| March 31, 2016 | -1.79 |
| December 31, 2015 | -1.70 |
| September 30, 2015 | -1.64 |
| June 30, 2015 | -1.65 |
| March 31, 2015 | -3.30 |
| December 31, 2014 | -3.279 |
| September 30, 2014 | -4.099 |
| June 30, 2014 | -4.099 |
| March 31, 2014 | -1.999 |
| June 30, 2013 | -1.67 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| EyePoint, Inc. | -3.502 |
| LENZ Therapeutics, Inc. | -3.595 |
| Merck & Co., Inc. | 3.553 |
| Zevra Therapeutics, Inc. | 2.154 |
| Bristol Myers Squibb Co. | 3.563 |